Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385799035> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W4385799035 endingPage "1136" @default.
- W4385799035 startingPage "1131" @default.
- W4385799035 abstract "Background Eosinophilic esophagitis (EoE) is a chronic, allergic disease of the esophagus. Current treatment options are limited. One experimental therapy is antibodies against interleukin-5 (IL-5). However, it is unknown why some patients respond to anti-IL-5 treatment whereas others do not. We sought to delineate predictors of histologic response to anti-IL-5 therapy in pediatric EoE. Methods This post hoc analysis of a multicenter, double-blind clinical trial (ClinicalTrial.gov identifier: NCT00358449) evaluated mepolizumab for the treatment of EoE in pediatric patients. Predictors were assessed for their association with a histologic response at week 12 of treatment. A histologic response was defined as either <15 eosinophils per hpf or a reduction in peak eosinophil counts by ≥50%. Predictors on univariate analysis with P < 0.10 were included in multivariate logistic regression models. Statistical significance for multivariate comparisons was set at P < 0.05. Results Patients with a higher BMI were more likely to attain histologic response at week 12, defined as <15 eosinophils per hpf [aOR, 1.31; 95% confidence interval (CI), 1.07–1.60; P = 0.008]. Higher BMI (aOR, 1.70; 95% CI, 1.06–2.74; P = 0.029) and signs of exudate plaques on endoscopy (aOR, 18.30; 95% CI, 2.11–158.53; P = 0.008) were significant predictors of histologic response at week 12 where a histologic response was defined as a reduction in peak eosinophil counts by ≥50% Conclusion Higher BMI and signs of exudative plaques on endoscopy may be predictors of histologic response in pediatric EoE patients treated with antibodies against IL-5. Further studies are needed to validate our findings." @default.
- W4385799035 created "2023-08-15" @default.
- W4385799035 creator A5022687921 @default.
- W4385799035 creator A5026309575 @default.
- W4385799035 creator A5037978423 @default.
- W4385799035 creator A5063950990 @default.
- W4385799035 date "2023-07-31" @default.
- W4385799035 modified "2023-10-14" @default.
- W4385799035 title "Predictors of histologic response to mepolizumab in pediatric eosinophilic esophagitis" @default.
- W4385799035 cites W1993044499 @default.
- W4385799035 cites W2033559734 @default.
- W4385799035 cites W2072486390 @default.
- W4385799035 cites W2086384139 @default.
- W4385799035 cites W2091963927 @default.
- W4385799035 cites W2535512767 @default.
- W4385799035 cites W2883311417 @default.
- W4385799035 cites W2890214828 @default.
- W4385799035 cites W2891288898 @default.
- W4385799035 cites W2996976309 @default.
- W4385799035 cites W3091479846 @default.
- W4385799035 cites W3193946021 @default.
- W4385799035 cites W3201668017 @default.
- W4385799035 cites W3217511170 @default.
- W4385799035 cites W4365517776 @default.
- W4385799035 doi "https://doi.org/10.1097/meg.0000000000002623" @default.
- W4385799035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37577798" @default.
- W4385799035 hasPublicationYear "2023" @default.
- W4385799035 type Work @default.
- W4385799035 citedByCount "0" @default.
- W4385799035 crossrefType "journal-article" @default.
- W4385799035 hasAuthorship W4385799035A5022687921 @default.
- W4385799035 hasAuthorship W4385799035A5026309575 @default.
- W4385799035 hasAuthorship W4385799035A5037978423 @default.
- W4385799035 hasAuthorship W4385799035A5063950990 @default.
- W4385799035 hasConcept C126322002 @default.
- W4385799035 hasConcept C144301174 @default.
- W4385799035 hasConcept C151956035 @default.
- W4385799035 hasConcept C2776042228 @default.
- W4385799035 hasConcept C2777037409 @default.
- W4385799035 hasConcept C2777832160 @default.
- W4385799035 hasConcept C2779134260 @default.
- W4385799035 hasConcept C2781065132 @default.
- W4385799035 hasConcept C38180746 @default.
- W4385799035 hasConcept C44249647 @default.
- W4385799035 hasConcept C67761136 @default.
- W4385799035 hasConcept C71924100 @default.
- W4385799035 hasConcept C90924648 @default.
- W4385799035 hasConceptScore W4385799035C126322002 @default.
- W4385799035 hasConceptScore W4385799035C144301174 @default.
- W4385799035 hasConceptScore W4385799035C151956035 @default.
- W4385799035 hasConceptScore W4385799035C2776042228 @default.
- W4385799035 hasConceptScore W4385799035C2777037409 @default.
- W4385799035 hasConceptScore W4385799035C2777832160 @default.
- W4385799035 hasConceptScore W4385799035C2779134260 @default.
- W4385799035 hasConceptScore W4385799035C2781065132 @default.
- W4385799035 hasConceptScore W4385799035C38180746 @default.
- W4385799035 hasConceptScore W4385799035C44249647 @default.
- W4385799035 hasConceptScore W4385799035C67761136 @default.
- W4385799035 hasConceptScore W4385799035C71924100 @default.
- W4385799035 hasConceptScore W4385799035C90924648 @default.
- W4385799035 hasIssue "10" @default.
- W4385799035 hasLocation W43857990351 @default.
- W4385799035 hasLocation W43857990352 @default.
- W4385799035 hasOpenAccess W4385799035 @default.
- W4385799035 hasPrimaryLocation W43857990351 @default.
- W4385799035 hasRelatedWork W1897577349 @default.
- W4385799035 hasRelatedWork W1967595860 @default.
- W4385799035 hasRelatedWork W1989690584 @default.
- W4385799035 hasRelatedWork W2086384139 @default.
- W4385799035 hasRelatedWork W2106574870 @default.
- W4385799035 hasRelatedWork W2150130664 @default.
- W4385799035 hasRelatedWork W2170749077 @default.
- W4385799035 hasRelatedWork W2785594448 @default.
- W4385799035 hasRelatedWork W2914217205 @default.
- W4385799035 hasRelatedWork W2977541676 @default.
- W4385799035 hasVolume "35" @default.
- W4385799035 isParatext "false" @default.
- W4385799035 isRetracted "false" @default.
- W4385799035 workType "article" @default.